Research develop a revolutionary toolkit to combat digital exclusion

Researchers create a composite indicator for digital exclusion and a related toolbox.

This Ex-President Also Survived an Assassination Attempt on the Campaign Trail

As they arrived in Milwaukee for this week’s Republican National Convention, reporters spotted a historical plaque on a hotel wall memorializing an assassination attempt on

July 16, 2024

invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding – Biotech Investments

EQS-News: invIOs GmbH / Key word(s): Study invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant

September 6, 2023

Sunstone Therapies Announces Expansion of Innovative Dyad Study – Psychedelic Alpha

Sunstone Therapies Announces Expansion of Innovative Dyad Study Expansion of Phase 2 pilot trial to assess MDMA-assisted therapy for adjustment disorder in dyads of patients

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.